| Protein biomarkers for multiple sclerosis: semi-quantitative analysis of cerebrospinal fluid candidate protein biomarkers in different forms of multiple sclerosis T Avsar, D Korkmaz, M Tütüncü, NO Demirci, S Saip, M Kamasak, A Siva, ... Multiple Sclerosis Journal 18 (8), 1081-1091, 2012 | 45 | 2012 |
| Infliximab is a plausible alternative for neurologic complications of Behçet disease B Zeydan, U Uygunoglu, S Saip, ON Demirci, E Seyahi, S Ugurlu, ... Neurology-Neuroimmunology Neuroinflammation 3 (5), 2016 | 37 | 2016 |
| Chronic cerebrospinal venous insufficiency: does ultrasound really distinguish multiple sclerosis subjects from healthy controls? F Kantarci, S Albayram, NO Demirci, A Esenkaya, D Uluduz, O Uysal, ... European radiology 22 (5), 970-979, 2012 | 15 | 2012 |
| Brief repeatable battery (BRB)-Turkish normative data A Bingol, S Yildiz, B Topçular, M Tutuncu, NO Demirci, U Uygunoglu, ... WILEY-BLACKWELL, 2012 | 9 | 2012 |
| CSF proteomics identifies specific and shared pathways for multiple sclerosis clinical subtypes T Avsar, İM Durası, U Uygunoğlu, M Tütüncü, NO Demirci, S Saip, ... PloS one 10 (5), e0122045, 2015 | 7 | 2015 |
| Cognitive dysfunction in multiple sclerosis in a Turkish cohort A Bingol, S Yidiz, M Tutuncu, NO Demirci, N Ahi, B Topçular, S Saip, ... JOURNAL OF NEUROLOGY 257, S186-S187, 2010 | 3 | 2010 |
| Validation of the Multiple Sclerosis Neuropsychological Screening Questionnaire in Turkish A Bingol, B Topcular, S Yildiz, M Tutuncu, O Demirci, S Saip, A Siva MULTIPLE SCLEROSIS JOURNAL 17, S401-S401, 2011 | 2 | 2011 |
| A patient with established primary progressive multiple sclerosis transitions to ‘secondary’relapsing–remitting disease course following a fulminant demyelinating episode M Tutuncu, NO Demirci, F Özer, S Saip, OH Kantarci, A Siva Multiple Sclerosis Journal 17 (10), 1262-1264, 2011 | 2 | 2011 |
| What are the predictors of disease progression in Turkish Multiple Sclerosis patients.(4702) NO Demirci, M Tutuncu, U Uygunoğlu, S Saip, A Siva Neurology 94 (15 Supplement), 2020 | | 2020 |
| Infliximab for Treatment Refractory Neuro-Behçet Syndrome (P2. 161) B Zeydan, U Uygunoglu, S Saip, O Demirci, E Seyahi, S Ugurlu, ... Neurology 86 (16 Supplement), 2016 | | 2016 |
| Proteomic Analysis in CSF Identified Subtype Specific and Shared Molecular Pathways for Multiple Sclerosis Clinical Phenotypes (P5. 216) T Avsar, İ Durasi, U Uygunoglu, M Tutuncu, N Demirci, S Saipoglu, ... Neurology 84 (14 Supplement), 2015 | | 2015 |
| Clinical follow-up of neuro-Behcet syndrome patients treated with infliximab B Zeydan, NO Demirci, U Uygunoglu, E Seyahi, S Ugurlu, S Saip, A Siva JOURNAL OF NEUROLOGY 260, S113-S114, 2013 | | 2013 |
| Impact of depression on quality of life in multiple sclerosis patients A Bingol, E Goksel, S Yildiz, U Uygunoglu, NO Demirci, A Altintas, S Saip, ... MULTIPLE SCLEROSIS JOURNAL 18, 489-490, 2012 | | 2012 |
| Proteomic analysis: identification of candidate protein biomarkers in the CSF and serum samples of patients with clinically different multiple sclerosis subtypes T Avsar, U Uygunoglu, M Tutuncu, NO Demirci, S Saip, A Siva, ET Turanli MULTIPLE SCLEROSIS JOURNAL 18, 263-264, 2012 | | 2012 |
| Long-term effects of cognitive rehabilitation in multiple sclerosis: six months follow-up B Topcular, A Bingol, S Yildiz, M Tutuncu, O Demirci, S Saip, A Siva MULTIPLE SCLEROSIS JOURNAL 17, S173-S174, 2011 | | 2011 |
| Is cognitive dysfunction in multiple sclerosis and Neuro-Behçet's disease similar?: P439 A Bingol, B Topcular, S Yildiz, P Kaya, M Tutuncu, O Demirci, D Uluduz, ... Journal of Neurology 258, 2011 | | 2011 |
